U.S. To Fund Moderna $176 Million For Bird Flu Vaccine Development

The United States government has entered into a $176 million agreement with pharmaceutical company Moderna. This agreement is geared towards the development of a pandemic influenza vaccine, specifically targeting bird flu in humans. The decision reflects a strategic effort to mitigate risks associated with zoonotic diseases—those that can be transmitted from animals to humans—highlighting the importance of proactive measures in public health. $Moderna(MRNA.US)$